Santiago, Pablito C.
HRN: 26-78-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/19/2025
03/26/2025
IV
2.25g
Q8H
Pneumonja
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes